The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival based on oncologist density in the United States: Do we need to redefine underserved areas for oncologic care?
 
Kathan Mehta
Stock and Other Ownership Interests - Celgene (I)
 
Sudeep Siddappa Malleshappa
No Relationships to Disclose
 
Smit Patel
No Relationships to Disclose
 
Tapan Mehta
No Relationships to Disclose
 
Smith Giri
No Relationships to Disclose
 
Leonard Joseph Appleman
Research Funding - Acerta Pharma (Inst); Agensys (Inst); Astellas Pharma (Inst); AVEO (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); Medivation/Astellas; Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Prometheus (Inst); Sotio (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer; Cerulean Pharma; Exelixis
 
Vida Almario Passero
No Relationships to Disclose
 
Rahul Atul Parikh
Stock and Other Ownership Interests - Gilead Sciences (I)
Consulting or Advisory Role - Bayer
Research Funding - Saladax Biomedical